Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
American Superconductor
AMSC
$1.43B
| $1.16M | ﹤0.01% |
66,373
-192
| -0.3% | -$3.07K |
|
|
KALV
2877
DELISTED
KalVista Pharmaceuticals
KALV
| $1.15M | ﹤0.01% |
48,161
+1,264
| +3% | +$33.1K |
|
|
ONCR
2878
DELISTED
Oncorus, Inc.
ONCR
| $1.15M | ﹤0.01% |
83,493
+25,477
| +44% | +$394K |
|
|
FUV
2879
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $1.15M | ﹤0.01% |
+3,344
| New | +$772K |
|
2880
Standard BioTools
LAB
$351M
| $1.15M | ﹤0.01% |
186,103
+455
| +0.2% | +$2.43K |
|
2881
Bank First Corp
BFC
$1.68B
| $1.15M | ﹤0.01% |
16,421
+899
| +6% | +$64.2K |
|
2882
Hackett Group
HCKT
$269M
| $1.15M | ﹤0.01% |
63,524
-1,812
| -3% | -$31.5K |
|
2883
Playboy Inc
PLBY
$133M
| $1.14M | ﹤0.01% |
+29,355
| New | +$1.24M |
|
2884
Amerant Bancorp
AMTB
$1.16B
| $1.14M | ﹤0.01% |
53,296
-4,709
| -8% | -$98.7K |
|
2885
Lakeland Industries
LAKE
$109M
| $1.14M | ﹤0.01% |
50,986
-16,673
| -25% | -$430K |
|
|
SIEN
2886
DELISTED
Sientra, Inc.
SIEN
| $1.14M | ﹤0.01% |
14,294
+1,137
| +9% | +$80.8K |
|
|
RRD
2887
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.13M | ﹤0.01% |
180,095
+150,271
| +504% | +$819K |
|
|
KDNY
2888
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.13M | ﹤0.01% |
79,991
+38,774
| +94% | +$620K |
|
|
CSSE
2889
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $1.12M | ﹤0.01% |
+27,054
| New | +$951K |
|
2890
West Bancorporation
WTBA
$473M
| $1.12M | ﹤0.01% |
40,298
+163
| +0.4% | +$4.37K |
|
2891
AXT Inc
AXTI
$3.07B
| $1.12M | ﹤0.01% |
101,583
| – | – |
|
2892
Business First Bancshares
BFST
$1.04B
| $1.11M | ﹤0.01% |
48,442
-144
| -0.3% | -$3.41K |
|
2893
Teekay
TK
$983M
| $1.11M | ﹤0.01% |
297,299
+89,839
| +43% | +$318K |
|
2894
BlueLinx
BXC
$416M
| $1.1M | ﹤0.01% |
+21,970
| New | +$1.08M |
|
2895
Atomera
ATOM
$197M
| $1.1M | ﹤0.01% |
51,334
+6,344
| +14% | +$130K |
|
2896
Hingham Institution for Saving
HIFS
$622M
| $1.1M | ﹤0.01% |
3,778
+275
| +8% | +$80.8K |
|
2897
Miller Industries
MLR
$569M
| $1.09M | ﹤0.01% |
27,674
-820
| -3% | -$35K |
|
2898
Vishay Precision Group
VPG
$1.17B
| $1.08M | ﹤0.01% |
31,747
-232
| -0.7% | -$7.7K |
|
2899
Crawford & Co Class A
CRD.A
$532M
| $1.08M | ﹤0.01% |
118,943
+8,585
| +8% | +$84.9K |
|
2900
LifeMD
LFMD
$176M
| $1.07M | ﹤0.01% |
90,891
+9,461
| +12% | +$109K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.